Prot# 04-0-207: A Phase 3, Long-Term, Open Label Study to Evaluate the Safety of Twice Daily Tacrolimus Cream-B 0.1% in the Treatment of Psoriasis

Project: Research project

StatusFinished
Effective start/end date6/30/0612/31/07

Funding

  • Astellas Pharma US. Inc. (04-0-207)